SOURCE: StockCall

StockCall

September 24, 2010 08:47 ET

Analyst Research on AmerisourceBergen and Omnicare -- Lobbying Efforts Goes Up

JOHANNESBURG, SOUTH AFRICA--(Marketwire - September 24, 2010) -  www.stockcall.com/ offers investors comprehensive research on the drugs wholesale industry and has completed analytical research on AmerisourceBergen Corporation (NYSE: ABC) and Omnicare Inc. (NYSE: OCR). Register with us today at www.stockcall.com/ to have free access to these researches. 

Pharmaceutical sales rose 2% year-over-year last month helping to boost sales of prescription wholesalers. New prescriptions were up a little over 6% as well. Strong end of summer sales figures are encouraging heading into fall when flu vaccinations typically provide a shot in the arm for the pharmaceutical industry. Other sectors of health care were also up for the month, which could mean the entire healthcare industry is stabilizing as a whole. Register now at https://stockcall.com/development/stockcall/page.php?name=register.html to have free access to our reports on the drugs wholesale industry.

www.stockcall.com/ is an online platform where investors doing their due-diligence on the drugs wholesale industry can have easy and free access to our analyst research and opinions on AmerisourceBergen Corporation and Omnicare Inc.; all investors need to do is register for a complimentary membership at https://stockcall.com/development/stockcall/page.php?name=register.html

While the positive prescription data bodes well for the industry, there is growing concern amongst investors regarding the increase in lobbying efforts by the top 3 pharmaceutical distributors. Lobbying spending for the big three went up by an average of 33% with AmerisourceBergen Corporation spending as much as $290,000 in the second quarter of 2010. Investors looking for free research on AmerisourceBergen Corporation are welcome to sign up at www.stockcall.com/ABC240910.pdf for our new report. 

The jump in lobbying efforts could be indicative of pharmaceutical wholesalers and distributors being displeased or concerned with the ramifications of healthcare reform. The previous spike in lobbying occurred just prior to the signing of the reform bill. Visit www.stockcall.com/ to see how companies in this industry have grown over the past years and how they are expected to perform in the future.
Also making news this week are the lawsuits against Omnicare Inc. The company has agreed to pay a total of $21.1 million to settle the case which stated that Omnicare overpriced its drugs to the Medicaid programs in two states, namely Michigan and Massachusetts, as compared to what they would charge private health insurers. Investors looking for complimentary research on Omnicare Inc. are welcome to sign up at www.stockcall.com/OCR240910.pdf for our new report. 

About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information